Science

Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.

nottingham.ac.uk

Jan 15, 2025, 13:40

Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X about a recent paper by John Robertson, Professor of Surgery of the Faculty of Medicine and Health Sciences at the University of Nottingham, published in Journal of Clinical Oncology:

“Fulvestrant Versus Anastrozole in Endocrine Therapy – Naïve Women With Hormone Receptor – Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

Prespecified final OS analysis from FALCON and updated safety information.”

“Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial”

Authors: John Robertson, Zhimin Shao, Shinzaburo Noguchi, Igor Bondarenko, Lawrence Panasci, Sandeep Singh, Shankar Subramaniam, Matthew Ellis.

Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.

More posts featuring Elisabetta Bonzano.

Breast Cancer cancer Elisabetta Bonzano FALCON Igor Bondarenko John Robertson Lawrence Panasci Matthew Ellis OncoDaily Oncology Sandeep Singh Shankar Subramaniam Shinzaburo Noguchi Zhimin Shao

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage